Drugs
Ohio State University researchers have made significant discoveries in cancer treatment, DNA repair, and heart failure. According to recent studies, cancer treatment with interleukin (IL)-2 therapy yields a 10% to 20% response rate in patients with metastatic melanoma or renal cell carcinoma. Additionally, DNA repair genes XPB and XPD
Drugs
Researchers at Princess Margaret Hospital, Toronto, Canada have made significant contributions to the understanding and treatment of various forms of cancer. A recent study published in Clinical Cancer Research explored the intratumor heterogeneity in gene expression profiles from patients with cervical cancer. The study used gene expression profiling to identify
Pharmaceutical industry
Novartis has recently made significant strides in the development of treatments for various diseases, including iron overload, Parkinson's disease dementia, and Alzheimer's disease. The company's commitment to innovation has led to the approval of its medication Exjade for the treatment of iron overload in
Pharmaceutical industry
Type 2 diabetes continues to be a growing concern for healthcare providers and patients worldwide. Eli Lilly and Company (LLY) and its partners have made significant strides in developing innovative treatments for this condition, with the latest results showing that exenatide, a medication in a new class of incretin mimetics,
Drugs
Researchers at Ohio State University have made significant strides in cancer research, focusing on various aspects of the disease, including cancer therapy, hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, and the impact of cigarette smoking on colorectal polyp recurrence. These studies aim to improve our understanding of cancer and develop effective
Drugs
Research conducted by scientists at Case Western Reserve University in the United States has revealed promising findings in the areas of cancer treatment and regenerative medicine. The studies, published in prominent scientific journals, investigate the potential of toco-trienol-rich fraction (TRF) from palm oil to induce apoptosis in prostate cancer cells,
Drugs
CytRx Corporation, a biopharmaceutical company, has been awarded a Small Business Innovative Research (SBIR) grant of approximately $222,000 to develop novel inhibitors for the treatment of type 2 diabetes and obesity. The grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the
Drugs
Recent studies from Switzerland, France, and Denmark have shed light on new approaches to managing diabetes. A study from Switzerland found that adding acarbose to existing treatments for type 2 diabetes improved life expectancy and quality-adjusted life expectancy, while a study from France discovered a potential biomarker for assessing compliance
Drugs
Scientists at The University of Texas M. D. Anderson Cancer Center have made a breakthrough in understanding how the estrogen hormone helps keep breast cancer cells alive. The researchers have identified a complex molecular pathway involving multiple genes and proteins, including breast cancer-associated protein 3 (BCA3) and SIRT1, which is
Drugs
New research in cancer genetics and gene therapy from Taiwan, Japan, and the United States has shed light on potential new treatments for the disease. A study from Taipei Medical University in Taiwan has reported on using molecular imaging to monitor the effectiveness of gene therapy in treating cancer. In
Drugs
Recent studies from the United States and Japan have made significant progress in the field of adenoviral gene therapy, showing promise in the treatment of various types of cancers. Researchers have been working to improve the efficacy and safety of adenoviral vectors, which have shown limited clinical efficacy in cancer
Drugs
Researchers in the United States and Italy have reported significant advances in cancer treatment, focusing on novel approaches to targeting cancer cells and angiogenesis. Study findings provide new insights into the potential of combining therapies to achieve better treatment outcomes while minimizing side effects. By investigating the role of G
